Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
3.350
+0.060 (1.82%)
Feb 5, 2025, 12:45 PM EST - Market open
Titan Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -5.89 | -5.57 | -10.21 | -8.78 | -18.24 | -16.46 | Upgrade
|
| Depreciation & Amortization | 0.01 | 0.11 | 0.2 | 0.22 | 0.29 | 0.24 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.02 | -1.76 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.05 | 1.01 | 1 | 1.51 | 0.01 | 0.57 | Upgrade
|
| Other Operating Activities | 0.02 | 0.02 | 0.45 | -0.63 | -0.28 | -0.76 | Upgrade
|
| Change in Accounts Receivable | -0 | -0.01 | 0.08 | 0.77 | 0.19 | 0.84 | Upgrade
|
| Change in Inventory | - | - | 0.19 | 0.04 | 0.29 | 0.26 | Upgrade
|
| Change in Accounts Payable | -0.08 | -0.48 | -0.75 | -1.19 | 1.1 | -0.13 | Upgrade
|
| Change in Unearned Revenue | -0.01 | -0.18 | -0.1 | 0.3 | - | -0.31 | Upgrade
|
| Change in Other Net Operating Assets | 0.3 | -0.25 | 0.97 | -0.13 | -0.56 | 0.29 | Upgrade
|
| Operating Cash Flow | -5.62 | -7.09 | -8.18 | -7.9 | -17.2 | -15.45 | Upgrade
|
| Capital Expenditures | -0 | -0 | - | -0.02 | -0.54 | -0.26 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.51 | 0.73 | - | - | - | - | Upgrade
|
| Investing Cash Flow | 0.5 | 0.73 | - | -0.02 | -0.54 | -0.26 | Upgrade
|
| Short-Term Debt Issued | - | 0.75 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.65 | - | Upgrade
|
| Total Debt Issued | - | 0.75 | - | - | 0.65 | - | Upgrade
|
| Short-Term Debt Repaid | - | -0.25 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -1.6 | - | Upgrade
|
| Total Debt Repaid | - | -0.25 | - | - | -1.6 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 0.5 | - | - | -0.95 | - | Upgrade
|
| Issuance of Common Stock | - | - | 4.98 | 8.84 | 18.88 | 11.27 | Upgrade
|
| Financing Cash Flow | 0.41 | 10 | 4.98 | 8.84 | 17.93 | 11.27 | Upgrade
|
| Net Cash Flow | -4.71 | 3.64 | -3.2 | 0.92 | 0.19 | -4.43 | Upgrade
|
| Free Cash Flow | -5.62 | -7.09 | -8.18 | -7.92 | -17.74 | -15.7 | Upgrade
|
| Free Cash Flow Margin | - | -3855.43% | -1469.12% | -519.13% | -366.74% | -602.73% | Upgrade
|
| Free Cash Flow Per Share | -6.54 | -9.43 | -12.18 | -16.28 | -94.05 | -409.95 | Upgrade
|
| Cash Interest Paid | 0.02 | 0.02 | - | - | 0.3 | 0.43 | Upgrade
|
| Levered Free Cash Flow | -1.93 | -5.65 | -4.73 | -4.61 | -3.73 | -3.64 | Upgrade
|
| Unlevered Free Cash Flow | -1.92 | -5.65 | -4.73 | -4.61 | -3.25 | -3.04 | Upgrade
|
| Change in Net Working Capital | -0.7 | 2.22 | -0.48 | 0.47 | -1.59 | -1.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.